Literature DB >> 30204491

Research advances in the regulation of the putative ovarian germline stem cell niche on female germline stem cells.

Yangchun Liu1,2, Jiao Xu1,3, Feiyin Zhu1,2, Haifeng Ye1,4, Chuan Hu1,4, Jian Huang1,4, Yuehui Zheng1,4.   

Abstract

Stem cells are ideal seeding cells, which have the potential for self-renewal and multiple differentiation, and they play a fundamental role in maintaining homeostasis and regenerating and repairing tissue. The discovery of female germline stem cells (FGSCs) brings much hope for the postnatal renewal of oocytes and solving some female infertility problems. Ovarian function declines with increasing female age. Moreover, ovarian germline stem cell niche-aging could be the main cause of ovarian senescence, which ultimately leads to decreased follicle generation, declining female fertility, and age-related diseases, such as osteoporosis and ovarian cancer. The ovarian germline stem cell niche is the surrounding microenvironment in which FGSCs live, and it helps control the biological characteristics of FGSCs in many ways, such as nutritional supply and immunological cytokine secretion. This paper reviews the knowledge about the ovarian germline stem cell niche and its probable regulatory mechanisms on FGSCs, which provides valuable scientific information and scope for the prevention and treatment of ovarian senescence. Abbreviations: BMP: bone morphogenetic protein; Dpp: decapentaplegic; FGSC: female germline stem cell; IL, interleukin; OGSC: ovarian germline stem cells; ROS: reactive oxygen species; TGF, transforming growth factor; TNF, tumor necrosis factor.

Entities:  

Keywords:  Niche; female germline stem cells; ovarian aging; ovarian germline stem cell niche

Mesh:

Year:  2018        PMID: 30204491     DOI: 10.1080/19396368.2018.1515272

Source DB:  PubMed          Journal:  Syst Biol Reprod Med        ISSN: 1939-6368            Impact factor:   3.061


  3 in total

Review 1.  Female germline stem cells: aging and anti-aging.

Authors:  Wenli Hong; Baofeng Wang; Yasha Zhu; Jun'e Wu; Li Qiu; Shuyi Ling; Ziqiong Zhou; Yuqing Dai; Zhisheng Zhong; Yuehui Zheng
Journal:  J Ovarian Res       Date:  2022-07-04       Impact factor: 5.506

2.  Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization.

Authors:  Zaher Merhi; Serin Seckin; Marco Mouanness
Journal:  Clin Exp Reprod Med       Date:  2022-08-31

3.  Normalized Ploidy Following 20 Consecutive Blastocysts with Chromosomal Error: Healthy 46, XY Pregnancy with IVF after Intraovarian Injection of Autologous Enriched Platelet-derived Growth Factors.

Authors:  E Scott Sills; Natalie S Rickers; Channel S Svid; J M Rickers; Samuel H Wood
Journal:  Int J Mol Cell Med       Date:  2019-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.